This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Asia
October 20-22, 2025
Westin MiyakoKyoto, Japan

Seiryu Ujiie
Head of Purification Technology Development Group at Chugai Pharmaceutical Co., Ltd.
Speaker

Profile

Seiryu Ujiie serves as head of the purification technology development group at Chugai Pharmaceutical Co., Ltd., bringing over 15 years of extensive experience and deep expertise in therapeutic antibody manufacturing process development. Since joining Chugai in 2009, he has been consistently involved in antibody process development, accumulating broad experience across innovative antibody-derived product process design, validation studies, scale-up, and GMP manufacturing. Specializing in purification process development, he focuses on developing and implementing innovative solutions to enhance production process efficiency and scalability. While concentrating on building new technological foundations that go beyond conventional approaches, he actively supports the career development of diverse team members and demonstrates cross-functional team leadership, contributing to both technological advancement and talent development.

Agenda Sessions

  • Keynote Address: Reboot and Go Beyond: Advancing Antibody Purification Process Design

    10:45